Mei He

发表

Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.

S. Libutti, D. Esposito, S. Hewitt, 2008, Cancer research.

Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype.

P. Meltzer, S. Davis, Yonghong Wang, 2014, The Journal of clinical endocrinology and metabolism.

Prevalence of Heterotypic Tumor/Immune Cell-In-Cell Structure In Vitro and In Vivo Leading to Formation of Aneuploidy

Mei He, Ying Wang, Shan Wang, 2013, PloS one.

CC-5079: a small molecule with MKP1, antiangiogenic, and antitumor activity.

S. Libutti, P. Schafer, Mei He, 2010, The Journal of surgical research.

Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.

E. Kebebew, N. Nilubol, Mei He, 2013, Thyroid : official journal of the American Thyroid Association.

Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity.

M. Willingham, Zhen Xiao, E. Kebebew, 2015, Carcinogenesis.

Molecular pathways associated with mortality in papillary thyroid cancer.

E. Kebebew, N. Nilubol, Mei He, 2011, Surgery.

American Association of Endocrine Surgeons Molecular pathways associated with mortality in papillary thyroid cancer

E. Kebebew, N. Nilubol, Mei He, 2011 .

Interleukin‐13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma

R. Puri, A. Fojo, E. Kebebew, 2012, Cancer.

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations

S. Libutti, D. Harlan, W. Linehan, 2009, PloS one.

Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization

Mei He, Hong Wu, Hui Wang, 2022, Frontiers in Genetics.

Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening

C. Austin, M. Shen, Ya-Qin Zhang, 2012, Journal of Translational Medicine.

CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer.

E. Kebebew, R. Rahbari, Mei He, 2011, Endocrine-related cancer.

miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3.

M. Merino, E. Kebebew, Y. Xiong, 2014, Endocrine-related cancer.

Cancer development and progression.

Mei He, S. Libutti, J. Rosen, 2007, Advances in experimental medicine and biology.

Performance comparison of SNP detection tools with illumina exome sequencing data—an assessment using both family pedigree information and sample-matched SNP array data

Ming Yi, Robert M. Stephens, Yongmei Zhao, 2014, Nucleic acids research.

A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.

S. Libutti, A. Dackiw, M. Zeiger, 2005, Surgery.

Identification of Differentially Expressed MicroRNA in Parathyroid Tumors

E. Kebebew, O. Clark, R. Rahbari, 2011, Annals of Surgical Oncology.

Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.

S. Libutti, S. Hewitt, A. Spiegel, 2009, Cancer research.

miR30a inhibits LOX expression and anaplastic thyroid cancer progression.

S. Davis, R. Smallridge, E. Kebebew, 2015, Cancer research.

A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay

E. Kohn, S. Libutti, H. Alexander, 2004, Journal of Translational Medicine.

TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.

M. Shen, Ya-Qin Zhang, E. Kebebew, 2013, Endocrine-related cancer.

MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.

T. Fojo, E. Kebebew, N. Nilubol, 2013, Surgery.

LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinase.

Qihong Huang, M. Herlyn, E. Skordalakes, 2014, Cancer research.

Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing.

M. Shen, E. Kebebew, N. Nilubol, 2012, The Journal of clinical endocrinology and metabolism.

Expression Signature Developed from a Complex Series of Mouse Models Accurately Predicts Human Breast Cancer Survival

J. Gillespie, S. Libutti, K. Hunter, 2009, Clinical Cancer Research.

Molecular and Cellular Pathobiology LIMD 2 Is a Small LIM-Only Protein Overexpressed in Metastatic Lesions That Regulates Cell Motility and Tumor Progression by Directly Binding to and Activating the Integrin-Linked Kinase

Qihong Huang, M. Herlyn, E. Skordalakes, 2014 .

Prospective screening in familial nonmedullary thyroid cancer.

M. Merino, E. Kebebew, F. Celi, 2013, Surgery.

CDC 23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer

E. Kebebew, R. Rahbari, Mei He, 2011 .

Quantitative reverse transcription polymerase chain reaction–based detection of thyroid‐specific gene expression in fine‐needle aspirate for thyroid cancer recurrence evaluation: A case report and review of the literature

E. Kebebew, R. Aufforth, N. Nilubol, 2015, Head & neck.